Free Trial

DocGo Inc. $DCGO Shares Purchased by American Century Companies Inc.

DocGo logo with Medical background

Key Points

  • American Century Companies Inc. significantly increased its stake in DocGo Inc. by 175.5%, acquiring an additional 793,640 shares during the first quarter, bringing its total ownership to approximately 1.22% of the company.
  • DocGo reported a loss of $0.11 EPS for the quarter, missing analysts' expectations, while generating $80.42 million in revenue, exceeding forecasts.
  • Analyst ratings for DocGo are mixed, with three analysts offering a "Buy" rating and three giving a "Hold" rating, while the average price target is set at $3.59.
  • Five stocks to consider instead of DocGo.

American Century Companies Inc. increased its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 175.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,245,894 shares of the company's stock after purchasing an additional 793,640 shares during the quarter. American Century Companies Inc. owned approximately 1.22% of DocGo worth $3,289,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Brandywine Global Investment Management LLC grew its stake in DocGo by 12.0% in the first quarter. Brandywine Global Investment Management LLC now owns 77,269 shares of the company's stock worth $204,000 after purchasing an additional 8,279 shares in the last quarter. Russell Investments Group Ltd. grew its stake in DocGo by 59.0% in the first quarter. Russell Investments Group Ltd. now owns 229,213 shares of the company's stock worth $605,000 after purchasing an additional 85,097 shares in the last quarter. Nuveen LLC bought a new position in DocGo in the first quarter worth approximately $649,000. Jefferies Financial Group Inc. grew its stake in DocGo by 6,874.1% in the first quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company's stock worth $5,358,000 after purchasing an additional 2,000,356 shares in the last quarter. Finally, Victory Capital Management Inc. grew its stake in DocGo by 546.1% in the first quarter. Victory Capital Management Inc. now owns 372,487 shares of the company's stock worth $983,000 after purchasing an additional 314,838 shares in the last quarter. Institutional investors own 56.44% of the company's stock.

DocGo Price Performance

NASDAQ DCGO traded up $0.07 during midday trading on Friday, hitting $1.58. 201,866 shares of the company traded hands, compared to its average volume of 444,827. The company has a market cap of $154.54 million, a PE ratio of -8.32 and a beta of 0.97. The company's 50-day simple moving average is $1.53 and its 200-day simple moving average is $2.04. DocGo Inc. has a 52 week low of $1.23 and a 52 week high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.05). The company had revenue of $80.42 million for the quarter, compared to the consensus estimate of $77.58 million. DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. DocGo has set its FY 2025 guidance at EPS. On average, research analysts predict that DocGo Inc. will post 0.25 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on DCGO shares. BTIG Research cut DocGo from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. Canaccord Genuity Group increased their target price on DocGo from $1.45 to $1.60 and gave the company a "hold" rating in a research report on Thursday, August 21st. Finally, Needham & Company LLC dropped their target price on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $3.59.

Read Our Latest Research Report on DocGo

DocGo Company Profile

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Recommended Stories

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.